Product: | Saquinavir Mesylate | ||||||||
---|---|---|---|---|---|---|---|---|---|
Catalog Number: | 13451 | ||||||||
CAS Number: | 149845-06-7 | ||||||||
Synonyms: |
(2S)-N1[(1S,2R)-3-[(3S,4aS,8aS)-3-[[(1,1-Dimethylethyl)amino]carbonyl]octahydro-2-(1H)-isoquinolinyl]-2-hydroxy-1-(phenylmethyl)propyl]-2-[(2-quinolinylcarbonyl)amino]butanediamide Mesylate; Fortovase; Invirase; Ro 31-8959 |
||||||||
Pricing: |
|
||||||||
Formula: | C38H50N6O5 • CH4O3S | ||||||||
Chemical Purity: | >98% | ||||||||
Molecular Weight: | 766.95 | ||||||||
Structure: | |||||||||
Appearance: | Solid | ||||||||
Category: | Anti-viral Compounds | ||||||||
Stability: | Stable under recommended storage conditions | ||||||||
Storage: |
Keep container tightly closed in a dry and well-ventilated place. Recommended storage temperature: 2-8°C. Store with desiccant |
||||||||
Transportation: |
Non-hazardous for transport |
||||||||
Literature References: |
McLean, K., et al., The HIV protease inhibitor saquinavir induces endoplasmic reticulum stress, autophagy, and apoptosis in ovarian cancer cells. Gynecol. Oncol. 112, 623-630, (2009); Stephan, C., et al., Safety and efficacy after switch to a saquinavir-containing antiretroviral regimen in protease inhibitor pretreated HIV-positive patients. Eur. J. Med. Res. 15, 369-376, (2010) |
||||||||
MSDS: | |||||||||
Description: |
Saquinavir is an HIV Protease Inhibitor used in antiretroviral therapy. It inhibits both HIV-1 and HIV-2 proteases. Studies have also looked at saquinavir as a possible anti-cancer agent |